Stock Snapshot from
Pfizer IncAdd to My Watchlist
PFE:USNew YorkIndustry: Medical-Drugs
- 29.12Last
- 0.19 -0.63%Today's Change
- 29.30Previous Close
- 52 Week Low - High
Earnings
| EPS: Year Actual ttm | 2.160 |
| EPS: Year Est. 12/13 ttm | 2.224 |
| EPS: Quarterly Actual 3/13 | 0.54 |
| EPS: Quarterly Est. 6/13 | 0.58 |
| Price/Earnings ttm | 13.49 |
| Relative Price/Earnings | 0.834 |
| Earnings Growth Rate | 18.69 |
Company Description
| Pfizer Inc. is a research-based, global pharmaceutical company that discovers, develops, manufactures, and markets medicines for humans and animals. The Company's products include prescription pharmaceuticals, non-prescription self-medications, and animal health products such as anti-infective medicines and vaccines. | |
| Revenue | $59 billion |
| Net Income | $15 billion |
| Total Assets | $186 billion |
| Employees | 91,500 |
| Web Site | www.pfizer.com |
Latest Headlines
- Pfizer to Split Off Rest of Zoetis Animal Health Business
- Novartis Expands Alzheimer’s Pursuit as Rivals’ Drugs Fail
- ‘Love Hormone’ Promises Safer Births After Pfizer Flop: Health
- Vitamins That Cost Pennies a Day Seen Delaying Dementia: Health
- Tudor Sells Stakes Apple, Emerging Markets ETF, Filing Shows
- Level Global Co-Founder Gets 6 1/2 Years in Prison for Fraud
- Boston Scientific’s Mahoney Says Watchman Critical to Growth
- Pain Therapeutics Falls Most Ever as Pfizer Reviews Alliance
- Pfizer Begins Selling Viagra Online to Combat Fake Versions
- Merck’s Liptruzet Wins U.S. FDA Approval to Lower Cholesterol
Watchlist
Unless indicated otherwise: intraday data is at least 15 minutes delayed; mutual fund NAVs are updated at the close of every market day; all prices are in the local currency; Time is ET.